NIH-funded research Sbir 2 grant

Improving epilepsy diagnosis with an automated EEG risk score

Official title: EpiScalp: An EEG Analytics Solution to Improve Diagnosis of Epilepsy

Funded at Neurologic Solutions, INC. · NIH-11168672 · Data updated 2026-11-12

This project will use an automated EEG tool called EpiScalp that produces a 0–1 risk score from 10–20 minutes of scalp EEG to help people with suspected seizures get a clearer epilepsy diagnosis.

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionNeurologic Solutions, INC.
NIH-funded
Lab location1 site (Mclean, United States)
Project startAugust 13, 2024
Project endJuly 31, 2027
Funding year2025
Award (this year)$1,215,146
NIH project number5R44NS137845-02
Project IDNIH-11168672 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are people with unexplained spells or suspected seizures who are undergoing routine scalp EEG recording.

Less likely to help

People whose epilepsy diagnosis is already firmly established by other tests, those monitored only with implanted intracranial EEG, or people with conditions that do not produce visible scalp EEG changes may not benefit.

What this research studies

EpiScalp is an EEG analytics algorithm that analyzes short routine scalp EEG recordings and outputs a 0–1 risk score for epilepsy. The team will further develop the software to better recognize epileptiform signals and to distinguish them from artifacts that can mimic seizures. They plan to validate the tool using clinical EEG recordings and compare its results to standard visual EEG review by clinicians. The goal is to reduce delays and errors in diagnosis so patients spend less time on incorrect treatments or unnecessary testing.

Why it matters

Potential benefit: If successful, EpiScalp could reduce epilepsy misdiagnosis, avoid unnecessary antiseizure medications, and speed patients to appropriate treatment.

How similar studies have gone: Previous automated EEG and machine-learning tools have shown promise at detecting epileptiform activity but have not yet eliminated high misdiagnosis rates, so this work builds on promising but still-imperfect approaches.

Where this research is happening

  • Neurologic Solutions, INC.
    Mclean, United States
    Active

Researchers

  • Principal investigator: Gotshalk, Andrew — Neurologic Solutions, INC.
  • Study coordinator: Gotshalk, Andrew

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.